Graduate School of Systems Life Sciences, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan.
Cytotechnology. 2006 Nov;52(3):227-33. doi: 10.1007/s10616-006-9003-x. Epub 2006 Sep 5.
We previously developed an in vitro immunization (IVI) protocol of human peripheral blood mononuclear cells (PBMC) for generating antigen-specific human antibodies. In order to clarify whether IVI protocolinduces antigen-specific B cell responses in PBMC, we analyzed family gene usage and sequence of the variable region gene of immunoglobulin heavy chain (VH gene) of the antibody produced from the in vitro immunized PBMC. Sequence homology analyses of VH gene demonstrated that a larger repertoire of B cells can be sensitized with mite-extract than with cholera toxin B subunit and rice allergen. Further, antigen-specific B cells were efficiently expanded by using CpG oligodeoxynucleotide as adjuvant. These results suggest that appropriate combination of sensitizing antigen and adjuvant is primarily important for expansion of antigen-specific B cells in IVI protocol.
我们之前开发了一种人外周血单核细胞(PBMC)的体外免疫(IVI)方案,用于产生抗原特异性的人抗体。为了阐明 IVI 方案是否在 PBMC 中诱导抗原特异性 B 细胞反应,我们分析了体外免疫 PBMC 产生的抗体的免疫球蛋白重链(VH 基因)可变区基因的家族基因使用和序列。VH 基因的序列同源性分析表明,与霍乱毒素 B 亚单位和大米过敏原相比,螨提取物可以致敏更多的 B 细胞。此外,使用 CpG 寡脱氧核苷酸作为佐剂可以有效地扩增抗原特异性 B 细胞。这些结果表明,在 IVI 方案中,适当的致敏抗原和佐剂的组合对于扩增抗原特异性 B 细胞是至关重要的。